The economics of genomic medicine workshop summary

Economic models are frequently used to anticipate the costs and benefits of new health care technologies, policies, and regulations. Economic studies also have been used to examine much more specific issues, such as comparing the outcomes and cost-effectiveness of two different drug treatments for t...

Descripción completa

Detalles Bibliográficos
Autores Corporativos: Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health (-), Institute of Medicine (U.S.). Board on Health Sciences Policy, Assessing the Economics of Genomic Medicine (Workshop)
Otros Autores: Berger, Adam C., autor (autor), Olson, Steve, 1956- autor
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : The National Academies Press [2013]
Colección:National Academies ebooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b44937088*spi
Descripción
Sumario:Economic models are frequently used to anticipate the costs and benefits of new health care technologies, policies, and regulations. Economic studies also have been used to examine much more specific issues, such as comparing the outcomes and cost-effectiveness of two different drug treatments for the same condition. These kinds of analyses offer more than just predictions of future health care costs. They provide information that is valuable when implementing and using new technologies. Unfortunately, however, these economic assessments are often limited by a lack of data on which to base the examination. This particularly affects health economics, which includes many factors for which current methods are inadequate for assessing, such as personal utility, social utility, and patient preference. To understand better the health economic issues that may arise in the course of integrating genomic data into health care, the Roundtable on Translating Genomic-Based Research for Health hosted a workshop in Washington, DC, on July 17-18, 2012, that brought together economists, regulators, payers, biomedical researchers, patients, providers, and other stakeholders to discuss the many factors that may influence this implementation. The workshop was one of a series that the roundtable has held on this topic, but it was the first focused specifically on economic issues.
Descripción Física:1 recurso electrónico (xix, 107 páginas) : ilustraciones
Formato:Forma de acceso: World Wide Web.
Bibliografía:Incluye referencias bibliográficas.
ISBN:9780309269681
9780309269704